|
|
|
| Revolutionize your approach to clinical trials at DPHARM: Disruptive Innovations to Modernize Clinical Research, taking place September 16–17, 2025, in Philadelphia. This conference showcases cutting-edge strategies and technologies designed to reduce patient and site burden, streamline operations, improve data quality, and accelerate access to therapies. |
|
|
|
|
By Dan Schell, chief editor, Clinical Leader | Synthetic control arms replace traditional control groups with carefully matched historical or real-world data, offering an option for rare diseases, ethical constraints, or when high-quality datasets exist. They can speed access to treatments, but success depends on rigorous data matching, upfront planning, and early regulatory engagement. | |
|
|
|
| FDA's Vision On PRO Collection For RWE | Webinar | Castor | In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies. |
|
|
| Regulatory Opportunities For Decentralized Clinical Trials | Article | By Anna Yang, Genentech, a member of the Roche Group, DIA | Project SHASTA, a pioneering effort to measure the benefits of decentralized trial elements, reveals significant regulatory opportunities that could shape the future of clinical research. |
|
|
| The Strategic Advantage Of eCOA And IRT | White Paper | Almac Clinical Technologies | The future lies in unified, interoperable eCOA–IRT solutions that streamline operations, improve data integrity, and enhance patient and site experience. |
|
|
|
| 3 IRT Tactics Being Used To Streamline Supply Logistics | Article | By Maxime Schuchewytsch, IQVIA Technologies | Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them. |
|
|
|
| Hope In The Dark: Value In Alzheimer's Disease Research And Treatment | Article | By Rob Abbott, ISPOR—The Professional Society for Health Economics and Outcomes Research | The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease. |
|
|
|
|
